{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:02:49Z","timestamp":1784289769443,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-21-19"],"award-info":[{"award-number":["320.6750.2024-21-19"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Elite Scientists Sponsorship Program by Beijing Association for science and technology","award":["BYESS2023226"],"award-info":[{"award-number":["BYESS2023226"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04387-3","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:55:10Z","timestamp":1779105310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lnc RNA GAPLINC affects triple-negative breast cancer progression through the miR-331-3p\/IGF2BP1 axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenya","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyue","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziguo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaocong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"4387_CR1","doi-asserted-by":"crossref","unstructured":"De A, Roychowdhury P, Bhuyan NR, Ko YT, Singh SK, Dua K et al. Folic Acid Functionalized diallyl trisulfide-solid lipid nanoparticles for targeting triple negative breast cancer. Molecules. 2023;28(3).","DOI":"10.3390\/molecules28031393"},{"issue":"1","key":"4387_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12935-022-02786-6","volume":"22","author":"R Han","year":"2022","unstructured":"Han R, Yang H, Ling C, Lu L. Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor. Cancer Cell Int. 2022;22(1):368.","journal-title":"Cancer Cell Int"},{"key":"4387_CR3","first-page":"101125","volume-title":"SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer","author":"X Li","year":"2025","unstructured":"Li X, Ge J, Wan M, Feng T, Li X, Zhang H, et al. SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer. Volume 61. New York, NY: Neoplasia; 2025. p. 101125."},{"issue":"1","key":"4387_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12957-020-01907-7","volume":"18","author":"LY Xia","year":"2020","unstructured":"Xia LY, Hu QL, Zhang J, Xu WY, Li XS. Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases. World J Surg Oncol. 2020;18(1):129.","journal-title":"World J Surg Oncol"},{"key":"4387_CR5","doi-asserted-by":"publisher","first-page":"1333839","DOI":"10.3389\/fonc.2023.1333839","volume":"13","author":"J Zheng","year":"2023","unstructured":"Zheng J, Hao H. The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer. Front Oncol. 2023;13:1333839.","journal-title":"Front Oncol"},{"issue":"1","key":"4387_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s40001-022-00839-0","volume":"27","author":"C Lin","year":"2022","unstructured":"Lin C, Cui J, Peng Z, Qian K, Wu R, Cheng Y, et al. Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis. Eur J Med Res. 2022;27(1):201.","journal-title":"Eur J Med Res"},{"key":"4387_CR7","doi-asserted-by":"publisher","first-page":"175883592095835","DOI":"10.1177\/1758835920958354","volume":"12","author":"KJ Lee","year":"2020","unstructured":"Lee KJ, Mann E, Wright G, Piett CG, Nagel ZD, Gassman NR. Exploiting DNA repair defects in triple negative breast cancer to improve cell killing. Therapeutic Adv Med Oncol. 2020;12:1758835920958354.","journal-title":"Therapeutic Adv Med Oncol"},{"key":"4387_CR8","doi-asserted-by":"publisher","first-page":"117899","DOI":"10.1016\/j.lfs.2020.117899","volume":"256","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Zarrabi A, Hushmandi K, Zarrin V, Moghadam ER, Zabolian A, et al. PD-1\/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs. Life Sci. 2020;256:117899.","journal-title":"Life Sci"},{"issue":"6","key":"4387_CR9","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s12094-022-03056-7","volume":"25","author":"Y Lv","year":"2023","unstructured":"Lv Y, Yin W, Zhang Z. Non-coding RNAs as potential biomarkers of gallbladder cancer. Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico. 2023;25(6):1489\u2013511.","journal-title":"Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico"},{"issue":"1","key":"4387_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41420-025-02667-7","volume":"11","author":"H Goyal","year":"2025","unstructured":"Goyal H, Kaur J. Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progression. Cell death discovery. 2025;11(1):376.","journal-title":"Cell death discovery"},{"issue":"5","key":"4387_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/cac2.12146","volume":"41","author":"W Xue","year":"2021","unstructured":"Xue W, Zheng Y, Shen Z, Li L, Fan Z, Wang W, et al. Involvement of long non-coding RNAs in the progression of esophageal cancer. Cancer Commun (London England). 2021;41(5):371\u201388.","journal-title":"Cancer Commun (London England)"},{"key":"4387_CR12","doi-asserted-by":"crossref","unstructured":"Poulet C, Njock MS, Moermans C, Louis E, Louis R, Malaise M et al. Exosomal long non-coding RNAs in lung diseases. Int J Mol Sci. 2020;21(10):15\u20136.","DOI":"10.3390\/ijms21103580"},{"issue":"1","key":"4387_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12929-020-00654-x","volume":"27","author":"TC Kuo","year":"2020","unstructured":"Kuo TC, Kung HJ, Shih JW. Signaling in and out: long-noncoding RNAs in tumor hypoxia. J Biomed Sci. 2020;27(1):59.","journal-title":"J Biomed Sci"},{"issue":"27","key":"4387_CR14","doi-asserted-by":"publisher","first-page":"42183","DOI":"10.18632\/oncotarget.9741","volume":"7","author":"P Yang","year":"2016","unstructured":"Yang P, Chen T, Xu Z, Zhu H, Wang J, He Z. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO. Oncotarget. 2016;7(27):42183\u201394.","journal-title":"Oncotarget"},{"issue":"5","key":"4387_CR15","first-page":"6770","volume":"15","author":"Z Zheng","year":"2018","unstructured":"Zheng Z, Zhu D, Zhao F, Han J, Chen H, Cai Y, et al. Upregulated GAPLINC predicts a poor prognosis in bladder cancer patients and promotes tumor proliferation and invasion. Oncol Lett. 2018;15(5):6770\u20136.","journal-title":"Oncol Lett"},{"key":"4387_CR16","doi-asserted-by":"crossref","unstructured":"Liao S, Zhou S, Wang C. GAPLINC is a predictor of poor prognosis and regulates cell migration and invasion in osteosarcoma. Biosci Rep. 2018;38(5):1\u20138.","DOI":"10.1042\/BSR20181171"},{"issue":"23","key":"4387_CR17","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.1158\/0008-5472.CAN-14-0686","volume":"74","author":"Y Hu","year":"2014","unstructured":"Hu Y, Wang J, Qian J, Kong X, Tang J, Wang Y, et al. Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. Cancer Res. 2014;74(23):6890\u2013902.","journal-title":"Cancer Res"},{"issue":"4","key":"4387_CR18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s10620-018-4915-9","volume":"63","author":"Y Luo","year":"2018","unstructured":"Luo Y, Ouyang J, Zhou D, Zhong S, Wen M, Ou W, et al. Long Noncoding RNA GAPLINC Promotes Cells Migration and Invasion in Colorectal Cancer Cell by Regulating miR-34a\/c-MET Signal Pathway. Dig Dis Sci. 2018;63(4):890\u20139.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"4387_CR19","first-page":"e3853","volume":"22","author":"S Soleimani","year":"2024","unstructured":"Soleimani S, Pouresmaeili F, Salahshoori Far I. Evaluation of lncRNAs as Potential Biomarkers for Diagnosis of Metastatic Triple-Negative Breast Cancer through Bioinformatics and Machine Learning. Iran J Biotechnol. 2024;22(3):e3853.","journal-title":"Iran J Biotechnol"},{"issue":"6","key":"4387_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10585-025-10377-8","volume":"42","author":"CD Coronado-Alvarado","year":"2025","unstructured":"Coronado-Alvarado CD, Astiazaran-Garcia H. Defining the Tumor-Bone axis: the role of extracellular vesicles in a crucial exchange route for breast cancer development and progression. Clin Exp Metastasis. 2025;42(6):59.","journal-title":"Clin Exp Metastasis"},{"key":"4387_CR21","doi-asserted-by":"publisher","first-page":"1499111","DOI":"10.3389\/fcell.2024.1499111","volume":"12","author":"F Dong","year":"2024","unstructured":"Dong F, Zhou J, Wu Y, Gao Z, Li W, Song Z. MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential. Front cell Dev biology. 2024;12:1499111.","journal-title":"Front cell Dev biology"},{"key":"4387_CR22","doi-asserted-by":"publisher","first-page":"153303382090582","DOI":"10.1177\/1533033820905824","volume":"19","author":"M Zhao","year":"2020","unstructured":"Zhao M, Zhang M, Tao Z, Cao J, Wang L, Hu X. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2. Technol Cancer Res Treat. 2020;19:1533033820905824.","journal-title":"Technol Cancer Res Treat"},{"issue":"3","key":"4387_CR23","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.jds.2024.04.031","volume":"19","author":"KY Liang","year":"2024","unstructured":"Liang KY, Su NY, Yang HP, Hsieh PL, Fang CY, Tsai LL, et al. Gastric adenocarcinoma predictive long intergenic noncoding RNA (GAPLINC) promotes oral cancer stemness by acting as a molecular sponge of miR331-3p. J Dent Sci. 2024;19(3):1389\u201395.","journal-title":"J Dent Sci"},{"key":"4387_CR24","doi-asserted-by":"publisher","first-page":"759267","DOI":"10.3389\/fphar.2021.759267","volume":"12","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang Q, Ke Z, Liu Y, Guo H, Fang S, et al. LINC01001 Promotes Progression of Crizotinib-Resistant NSCLC by Modulating IGF2BP2\/MYC Axis. Front Pharmacol. 2021;12:759267.","journal-title":"Front Pharmacol"},{"issue":"12","key":"4387_CR25","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1158\/1541-7786.MCR-23-0478","volume":"22","author":"H Sui","year":"2024","unstructured":"Sui H, Shi C, Yan Z, Chen J, Man L, Wang F. LRRC75A-AS1 Drives the Epithelial-Mesenchymal Transition in Cervical Cancer by Binding IGF2BP1 and Inhibiting SYVN1-Mediated NLRP3 Ubiquitination. Mol cancer research: MCR. 2024;22(12):1075\u201387.","journal-title":"Mol cancer research: MCR"},{"issue":"6","key":"4387_CR26","first-page":"108","volume":"70","author":"M Chen","year":"2024","unstructured":"Chen M, Shen Y. Oridonin represses lung cancer cell proliferation and migration by modulating AFAP1-AS1\/IGF2BP1. Cellular and molecular biology. France). 2024;70(6):108\u201313. (Noisy-le-Grand.","journal-title":"France)"},{"issue":"22","key":"4387_CR27","first-page":"1115","volume":"30","author":"Y Yang","year":"2021","unstructured":"Yang Y, Wu J, Liu F, He J, Wu F, Chen J, et al. IGF2BP1 Promotes the Liver Cancer Stem Cell Phenotype by Regulating MGAT5 mRNA Stability by m6A RNA Methylation. Stem Cells Dev. 2021;30(22):1115\u201325.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"4387_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13578-022-00772-z","volume":"12","author":"W Shi","year":"2022","unstructured":"Shi W, Tang Y, Lu J, Zhuang Y, Wang J. MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification. Cell bioscience. 2022;12(1):38.","journal-title":"Cell bioscience"},{"issue":"3","key":"4387_CR29","doi-asserted-by":"publisher","first-page":"152802","DOI":"10.1016\/j.prp.2019.152802","volume":"216","author":"X Wang","year":"2020","unstructured":"Wang X, Liu Y. PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer. Pathol Res Pract. 2020;216(3):152802.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"4387_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13058-024-01858-x","volume":"26","author":"Y Fang","year":"2024","unstructured":"Fang Y, Wang Y, Ma H, Guo Y, Xu R, Chen X, et al. TFAP2A downregulation mediates tumor-suppressive effect of miR-8072 in triple-negative breast cancer via inhibiting SNAI1 transcription. Breast cancer research: BCR. 2024;26(1):103.","journal-title":"Breast cancer research: BCR"},{"issue":"1","key":"4387_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2478\/jtim-2019-0002","volume":"7","author":"J Liang","year":"2019","unstructured":"Liang J, Chen W, Lin J. LncRNA: An All-rounder in Rheumatoid Arthritis. J translational Intern Med. 2019;7(1):3\u20139.","journal-title":"J translational Intern Med"},{"issue":"8","key":"4387_CR32","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/CAD.0000000000000752","volume":"30","author":"W Zhang","year":"2019","unstructured":"Zhang W, Yao H, Wu Y. Poor expression of long-chain noncoding RNA GAPLINC inhibits epithelial-mesenchymal transition, and invasion and migration of hepatocellular carcinoma cells. Anticancer Drugs. 2019;30(8):784\u201394.","journal-title":"Anticancer Drugs"},{"key":"4387_CR33","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.2147\/OTT.S165147","volume":"11","author":"L Diao","year":"2018","unstructured":"Diao L, Wang S, Sun Z. Long noncoding RNA GAPLINC promotes gastric cancer cell proliferation by acting as a molecular sponge of miR-378 to modulate MAPK1 expression. OncoTargets therapy. 2018;11:2797\u2013804.","journal-title":"OncoTargets therapy"},{"key":"4387_CR34","doi-asserted-by":"publisher","first-page":"718532","DOI":"10.3389\/fonc.2021.718532","volume":"11","author":"S Wang","year":"2021","unstructured":"Wang S, Yang X, Xie W, Fu S, Chen Q, Li Z, et al. LncRNA GAPLINC Promotes Renal Cell Cancer Tumorigenesis by Targeting the miR-135b-5p\/CSF1 Axis. Front Oncol. 2021;11:718532.","journal-title":"Front Oncol"},{"key":"4387_CR35","doi-asserted-by":"crossref","unstructured":"Zhan J, Yin Q, Zhao P, Hong L. Role and mechanism of the lncRNA SNHG1\/miR\u2013450b\u20135p\/IGF1 axis in the regulation of myocardial ischemia reperfusion injury. Mol Med Rep. 2022;25(5):1\u20139.","DOI":"10.3892\/mmr.2022.12692"},{"issue":"1","key":"4387_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41420-022-01061-x","volume":"8","author":"J Xu","year":"2022","unstructured":"Xu J, Xu J, Liu X, Jiang J. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. Cell death discovery. 2022;8(1):287.","journal-title":"Cell death discovery"},{"issue":"1","key":"4387_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00401-024-02788-w","volume":"148","author":"NK Leclair","year":"2024","unstructured":"Leclair NK, Lucas CG, Mirchia K, McCortney K, Horbinski CM, Raleigh DR, et al. The RNA-binding protein IGF2BP1 regulates stability of mRNA transcribed from FOXM1 target genes in hypermitotic meningiomas. Acta Neuropathol. 2024;148(1):28.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"4387_CR38","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1186\/s12885-025-14390-8","volume":"25","author":"Y Pan","year":"2025","unstructured":"Pan Y, Yang H, Zhang J, Zhang R, Liu Y, Bie J, et al. CircSLC22A3 inhibits the invasion and metastasis of ESCC via the miR-19b-3p\/TRAK2 axis and by reducing the stability of m(6)A-modified ACSBG1 mRNA. BMC Cancer. 2025;25(1):971.","journal-title":"BMC Cancer"},{"key":"4387_CR39","doi-asserted-by":"publisher","first-page":"6545728","DOI":"10.1155\/2021\/6545728","volume":"2021","author":"B Yang","year":"2021","unstructured":"Yang B, Chen Q. Cross-Talk between Oxidative Stress and m(6)A RNA Methylation in Cancer. Oxidative Med Cell Longev. 2021;2021:6545728.","journal-title":"Oxidative Med Cell Longev"},{"issue":"5","key":"4387_CR40","doi-asserted-by":"publisher","first-page":"101567","DOI":"10.1016\/j.gendis.2025.101567","volume":"12","author":"L Qiu","year":"2025","unstructured":"Qiu L, Wu S, Zhang L, Li W, Xiang D, Kasim V. The biological roles and molecular mechanisms of m6A reader IGF2BP1 in the hallmarks of cancer. Genes Dis. 2025;12(5):101567.","journal-title":"Genes Dis"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04387-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04387-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04387-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:03:01Z","timestamp":1784286181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04387-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4387"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04387-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by The Ethics Committee of The First People\u2019s Hospital of Jingdezhen and followed the principles outlined in the Declaration of Helsinki. In addition, informed consent has been obtained from the participants involved.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"301"}}